IM Cannabis annual gross margin
2019
2020
2021
2022
2023
2024
2025
IM Cannabis's gross margin was 17.70% for fiscal 2025.
View full IM Cannabis company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 17.70% | +2.06 pp |
| 2024 | 2024-12-31 | 15.64% | −4.53 pp |
| 2023 | 2023-12-31 | 20.17% | +3.31 pp |
| 2022 | 2022-12-31 | 16.86% | −1.74 pp |
| 2021 | 2021-12-31 | 18.60% | −47.28 pp |
| 2020 | 2020-12-31 | 65.88% | +22.58 pp |
| 2019 | 2019-12-31 | 43.30% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2025 | 2025-06-30 | 26.98% | +32.09 pp |
| Q2 2024 | 2024-06-30 | 5.72% | — |
| Q2 2023 | 2023-06-30 | 26.17% | — |
| Q2 2022 | 2022-06-30 | 17.33% | — |
| Q2 2021 | 2021-06-30 | −5.11% | — |
Over the last five reported fiscal years, IM Cannabis's gross margin decreased from 65.88% to 17.70%, a change of −48.18 percentage points. The latest reported quarter, Q2 2025, shows 26.98%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review IM Cannabis filings at SEC.gov ↗